Biotech | July 07, 2025
Godavari Biorefineries' anti-cancer patent now validated in Spain and UK
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
ARGX-119 is the sixth molecule developed through our Immunology Innovation Program to show proof-of-concept
Surpassing 1,000 Company Owned Company Operated stores
A triple-action Formula for comprehensive respiratory relief
Treatment with XPro was well-tolerated and safe, even in the high risk ApoE4+/+ patient group, and ARIA-E or ARIA-H was not observed in any patients
New findings reveal bemarituzumab plus chemotherapy significantly improves survival in advanced gastric cancer, offering hope for targeted treatment options
mRNA-1010 demonstrated superior relative vaccine efficacy
Extended lab space for product development, customer demos, and training
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
Subscribe To Our Newsletter & Stay Updated
